Search hospitals > Wisconsin > Milwaukee
Children's Hospital of Wisconsin
Claim this profileMilwaukee, Wisconsin 53226
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Recurrence
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
414 reported clinical trials
26 medical researchers
Summary
Children's Hospital of Wisconsin is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Leukemia, Tumors, Recurrence, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. Children's Hospital of Wisconsin is involved with conducting 414 clinical trials across 642 conditions. There are 26 research doctors associated with this hospital, such as Paul D. Harker-Murray, Meghen B. Browning, Michael Burke, MD, and Peter H. Shaw.Area of expertise
1Leukemia
Global LeaderStage IV
Philadelphia chromosome positive
Stage II
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Paul D. Harker-MurrayChildren's Hospital of Wisconsin6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
19 reported clinical trials
26 drugs studied
Meghen B. BrowningChildren's Hospital of Wisconsin18 years of reported clinical research
Studies Tumors
Studies Neuroblastoma
16 reported clinical trials
40 drugs studied
Michael Burke, MDChildren's Hospital of Wisconsin1 year of reported clinical research
Expert in Leukemia
Studies Acute Lymphoblastic Leukemia
14 reported clinical trials
43 drugs studied
Peter H. ShawJohns Hopkins All Children's Hospital4 years of reported clinical research
Studies Leukemia
Studies Lymphoma
9 reported clinical trials
35 drugs studied
Clinical Trials running at Children's Hospital of Wisconsin
Acute Lymphoblastic Leukemia
Brain Tumor
Leukemia
Osteosarcoma
Lymphoblastic Leukemia-Lymphoma
Germ Cell Tumors
Rhabdoid Tumor
Non-Hodgkin's Lymphoma
Tumors
Lymphoma
Imatinib + Chemotherapy
for Acute Lymphoblastic Leukemia
This study is evaluating whether a combination of drugs may help treat patients with a specific type of leukemia.
Recruiting2 awards Phase 3
Levocarnitine
for Chemotherapy-Related Liver Protection in Leukemia and Lymphoma
This phase III trial compares the effect of adding levocarnitine to standard chemotherapy vs. standard chemotherapy alone in protecting the liver in patients with leukemia or lymphoma. Asparaginase is part of the standard of care chemotherapy for the treatment of acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), and mixed phenotype acute leukemia (MPAL). However, in adolescent and young adults (AYA) ages 15-39 years, liver toxicity from asparaginase is common and often prevents delivery of planned chemotherapy, thereby potentially compromising outcomes. Some groups of people may also be at higher risk for liver damage due to the presence of fat in the liver even before starting chemotherapy. Patients who are of Japanese descent, Native Hawaiian, Hispanic or Latinx may be at greater risk for liver damage from chemotherapy for this reason. Carnitine is a naturally occurring nutrient that is part of a typical diet and is also made by the body. Carnitine is necessary for metabolism and its deficiency or absence is associated with liver and other organ damage. Levocarnitine is a drug used to provide extra carnitine. Laboratory and real-world usage of the dietary supplement levocarnitine suggests its potential to prevent or reduce liver toxicity from asparaginase. The overall goal of this study is to determine whether adding levocarnitine to standard of care chemotherapy will reduce the chance of developing severe liver damage from asparaginase chemotherapy in ALL, LL and/or MPAL patients.
Recruiting2 awards Phase 3
Blinatumomab + Chemotherapy
for Leukemia
This study is evaluating whether a combination of chemotherapy and a monoclonal antibody may be more effective than chemotherapy alone in treating patients with B-lymphoblastic leukemia or B-ly
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital of Wisconsin?
Children's Hospital of Wisconsin is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Leukemia, Tumors, Recurrence, Lymphoma, Lymphoblastic Leukemia-Lymphoma and other specialties. Children's Hospital of Wisconsin is involved with conducting 414 clinical trials across 642 conditions. There are 26 research doctors associated with this hospital, such as Paul D. Harker-Murray, Meghen B. Browning, Michael Burke, MD, and Peter H. Shaw.
Where is Children's Hospital of Wisconsin located?
**Children's Hospital of Wisconsin**
- **Address:** 8915 W Connell Ct, Milwaukee, WI 53226
- **Directions:** From I-94 W, take exit 309B for 84th St towards Wauwatosa. Turn right onto W North Ave, then left onto N 84th St. After 0.5 miles, turn right onto W Connell Ave. The hospital is on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Children's Hospital of Wisconsin, contact them at (414) 266-6262 or via email at FinancialAssistance@childrenswi.org. For insurance inquiries, reach out to their main switchboard at (414) 266-2000 or toll-free at (877) 266-8989. Their mailing address is 8915 W. Connell Ct. P.O. Box 1997, Milwaukee, WI 53226.
What insurance does Children's Hospital of Wisconsin accept?
Children's Hospital of Wisconsin accepts a wide range of insurance plans, ensuring access to high-quality healthcare for its patients. Among these, Chorus Community Health Plans (CCHP), an affiliate of Children's Wisconsin, offers BadgerCare Plus in 28 counties and Individual and Family Plans across 15 counties in eastern Wisconsin. Additionally, the hospital is in-network with numerous other insurers, including but not limited to Aetna, Anthem Wisconsin, Cigna Health Plan, Humana, Medicaid Wisconsin, Medicare, and UnitedHealthcare.
What awards or recognition has Children's Hospital of Wisconsin received?
Children's Hospital of Wisconsin in Milwaukee is renowned for its outstanding patient care, employer practices, and community partnerships. It has also been recognized for its significant contributions to pediatric science through its nursing research and evidence-based practice department. This department has developed a support network for pediatric nurse scientists, fostering nurse-led, collaborative research across various disciplines and sites.